Non-ownership Filings
| Change of name to Argent BioPharma Limited | Apr. 02, 2024 |
| Refinancing of Convertible Securities Agreement | Mar. 28, 2024 |
| Results of General Meeting | Mar. 18, 2024 |
| Update - Application for Admission to Trading | Feb. 19, 2024 |
| Dispatch of General Meeting Documents | Feb. 13, 2024 |
| Application for Admission to Trading | Feb. 13, 2024 |
| December 2023 Quarter Activity Report | Jan. 31, 2024 |
Ownership Update Filings
| PDMR Notification | Mar. 28, 2024 |
| Director/PDMR Shareholding | Jan. 11, 2024 |
| Holding(s) in Company | Nov. 16, 2023 |
| Holding(s) in Company | Nov. 13, 2023 |
| Holding(s) in Company | Nov. 09, 2023 |
| Holding(s) in Company | Nov. 08, 2023 |
| Share Purchase Plan Closed | Aug. 30, 2023 |